专利号:WO-2023098592-A1 优先权日:2021-11-30 标题:Preparation method for carbon-loaded iron-based catalyst and use thereof in synthesis of intermediates of anti-cancer inhibitors
专利号:US-12390420-B1 优先权日:2024-10-22 标题 :Compositions for targeted delivery of therapeutic agents and methods for the synthesis and use thereof 发明人:EGUCHI MASAKATSU 权利人:BRYET US INC 摘要:The present disclosure provides compositions and methods for delivering therapeutic agents to particular tissues or cells in a subject. The composition disclosed herein combines unique properties of porous micro- or nano-particles with host-guest chemistry provided by functionalized silicon particle, offering a versatile approach to addressing the challenges associated with delivering therapeutic agents to target tissues or sites within the body. The present disclosure also provides a method for synthesizing a composition capable of delivering therapeutic agents to particular tissues or cells in a subject.
专利号:CN-114315595-B 优先权日:2021-11-30 标题 :Preparation method of a carbon-supported iron-based catalyst and its application in the synthesis of anti-cancer inhibitor intermediates
专利号:US-10272065-B2 优先权日:2013-01-14 标题 :Gem-difluorinated C-glycoside compounds as anti-cancer agents 发明人:SLILATY STEVE N 权利人:ADVANOMICS CORP; BENOIT & COTE 摘要:The present document describes a synthesis of a class of gem-difluorinated C-glycoside compounds derived from podophyllotoxin, which may be used, but not exclusively, in oncology for the treatment of cancer. More particularly, the podophyllotoxin gem-difluorinated C-glycoconjugated derivatives display improved conformational and chemical stability, and improved cytotoxicity exhibited against drug-resistant cancer cell lines.
专利号:US-2022233727-A1 优先权日:2019-06-13 标题:Surface enhanced raman scattering nanoparticles and their use in detecting and imaging oxidative stress 发明人:THAKOR AVNESH S; RAZAVI MEHDI 权利人:UNIV LELAND STANFORD JUNIOR 摘要:Surface enhanced Raman scattering (SERS) nanoparticles and methods of using them for detecting reactive oxygen species are disclosed. In particular, methods of using SERS nanoparticles to detect and quantify reactive oxygen species Synthesis and monitor oxidative stress and disease-relevant changes in levels of reactive oxygen species are provided.
专利号:CN-114315595-A 优先权日:2021-11-30 标题:Preparation method of carbon-supported iron-based catalyst and synthesis application of anti-cancer inhibitor intermediate thereof
1: Nan T, Cai R, Lian S, Wu X, Wei X, Ye X, Cai Y, Su Y, Wei J. Efficacy and safety of apatinib for the treatment of extensive-stage small cell lung cancer in Chinese patients: a single-arm systematic review and meta-analysis. Chin Clin Oncol. 2025 Dec;14(6):67. doi: 10.21037/cco-25-34. 16:1653429. doi: 10.3389/fimmu.2025.1653429. 3: Li Y, Liang Y, Ye P, Chen G, Zhang Y, Chen M, Xiong W, Yang X, Zhang X. Effectiveness and safety of camrelizumab plus apatinib in treating recurrent/metastatic nasopharyngeal carcinoma: a single-arm meta-analysis. Eur Arch Otorhinolaryngol. 2025 Nov;282(11):5509-5518. doi: 10.1007/s00405-025-09482-x. Epub 2025 May 31. 25(1):564. doi: 10.1186/s12885-025-13932-4.
合成参考文献
摘要:Liang S, Tong XZ, Fu LW. [Inhibitory effect of apatinib on HL-60 cell proliferation and its mechanism]. Nan Fang Yi Ke Da Xue Xue Bao. 2011 May;31(5):871–4. 参考文献:10.1080/07357907.2016.1276185 摘要:Roviello G, Polom K, Roviello F, Marrelli D, Multari AG, Paganini G, Pacifico C, Generali D. Targeting VEGFR-2 in Metastatic Gastric Cancer: Results From a Literature-Based Meta-Analysis. Cancer Invest. 2017 Mar 16;35(3):187–94. doi: 10.1080/07357907.2016.1276185. 参考文献:10.18632/oncotarget.15036 摘要:Lin Y, Wang C, Gao W, Cui R, Liang J. Overwhelming rapid metabolic and structural response to apatinib in radioiodine refractory differentiated thyroid cancer. Oncotarget. 2017 Jun 27;8(26):42252–61. 参考文献:10.1097/md.0000000000016065 摘要:Jiang Q, Zhang NL, Ma DY, Tan BX, Hu X, Fang XD. Efficacy and safety of apatinib plus docetaxel as the second or above line treatment in advanced nonsquamous NSCLC: A multi center prospective study. Medicine (Baltimore). 2019 Jun;98(26):e16065. 参考文献:10.1002/jcb.29242 摘要:Gu J, Shu D, Su F, Xie Y, Liang X. Analysis of metabolome changes in the HepG2 cells of apatinib treatment by using the NMR-based metabolomics. J Cell Biochem. 2019 Nov;120(11):19137–46. doi: 10.1002/jcb.29242.